Dr. William Soliman is the Founder and CEO of the Accreditation Council for Medical Affairs (ACMA). He is a pharma industry futurist with over 15 years of experience in the industry working with several companies such as Merck, Abbvie, Gilead Sciences, and Eisai among others. He is passionate about transforming the industry through benchmarking and technology.
Dr. Soliman was invited in March 2021 before the United States Congress, Health Subcommittee with Republican Congressman Brett Guthrie to discuss healthcare, the pharmaceutical industry, and the importance of professional standards for those professionals who engage healthcare providers. Additionally, Dr. Soliman was invited in June 2021 as a speaker at the U.S. Attorney General Alliance Meeting.
Dr. Soliman received his Ph.D. from Columbia University & his Bachelors from New York University.
Biosimilars represent an important therapeutic option in modern healthcare, offering cost-effective alternatives to complex biological drugs. The educational gap among healthcare professionals poses a challenge to their widespread adoption. Medical Affairs teams in the pharmaceutical industry are at the forefront of bridging this gap